Healthcare

Sector Overview

The healthcare sector plays a critical role in the global economy by ensuring the well-being of populations and mitigating health-related challenges. It consists of various segments including pharmaceuticals, biotechnology, medical devices, and healthcare services, representing a blend of innovation and essential services. Top companies such as Boston Scientific Corporation and Medline Inc. focus on advanced medical technologies and essential health products, respectively, while others like BioAge Labs, Inc. and Zenas BioPharma, Inc. emphasize cutting-edge biopharmaceutical research. The increasing demand for healthcare services, particularly among aging populations and in the context of chronic disease management, has made this sector vital for economic growth and stability.

Key drivers of the healthcare sector include technological advancements, regulatory policies, and population health dynamics. The rapid development of biotechnology and personalized medicine, as seen with companies like Bicara Therapeutics, Inc. and Picard Medical, Inc., highlights the shift towards more targeted and efficient treatments, thereby enhancing patient outcomes. Moreover, trends such as telemedicine adoption and digital health innovations through firms like Omada Health and Butterfly Network, Inc. are reshaping service delivery, making healthcare more accessible and efficient. As healthcare continues to advance with innovations and a focus on preventive care, its significance in enhancing quality of life and driving economic development cannot be overstated.

Key Metrics

*Weighted by Market Cap Last updated: Jun 21, 2026
Avg P/E Ratio 27.2
Profitable Companies 92%
Avg Growth 10.3%
Avg Dividend Yield 0.20%

Historical Return

Last updated: Jun 15, 2026
1 Year +6.0% +0.2% Div
3 Years Ø +5.1% +0.2% Div
5 Years Ø +1.1% +0.2% Div
1 Year +28.1% +0.2% Div
3 Years Ø +4.8% +0.2% Div
5 Years Ø +0.4% +0.2% Div

Risk & Analysis Metrics

Last updated: Jun 21, 2026

Volatility

7.14% 1 Year
5.92% 3 Years
6.74% 5 Years
23.75% 10 Years

Max Drawdown

-4.20% 1 Year
-4.30% 3 Years
-4.35% 5 Years
-4.55% 10 Years

Sharpe Ratio

0.47 1 Year
0.51 3 Years
0.60 5 Years
2.06 10 Years

Volatility

1098.27% 1 Year
98.89% 3 Years
24.16% 5 Years
179.69% 10 Years

Max Drawdown

-4.17% 1 Year
-8.69% 3 Years
-11.96% 5 Years
-8.17% 10 Years

Sharpe Ratio

3.08 1 Year
0.79 3 Years
0.74 5 Years
0.72 10 Years

Return Triangle (Heatmap)

Last updated: Jun 15, 2026
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
2011 -14.4% -10.2% -4.3% -3.8% -3.3% -3.0% -2.4% -2.1% -1.4% -2.3% -2.2% -2.5% -1.0% -0.6% -0.4%
2012 -5.8% 1.2% 0.0% -0.4% -0.5% -0.2% -0.2% 0.4% -0.9% -0.9% -1.3% 0.2% 0.6% 0.7%
2013 8.8% 3.0% 1.5% 0.8% 0.9% 0.8% 1.3% -0.3% -0.4% -0.8% 0.8% 1.1% 1.2%
2014 -2.4% -1.9% -1.7% -1.0% -0.7% 0.1% -1.5% -1.5% -1.9% 0.0% 0.5% 0.6%
2015 -1.4% -1.3% -0.5% -0.3% 0.7% -1.3% -1.3% -1.8% 0.3% 0.8% 0.9%
2016 -1.2% 0.0% 0.1% 1.2% -1.3% -1.3% -1.8% 0.5% 1.0% 1.1%
2017 1.2% 0.8% 2.0% -1.4% -1.3% -1.9% 0.7% 1.3% 1.4%
2018 0.3% 2.4% -2.2% -2.0% -2.6% 0.7% 1.3% 1.4%
2019 4.5% -3.5% -2.7% -3.3% 0.7% 1.5% 1.5%
2020 -10.8% -6.2% -5.7% -0.2% 0.8% 1.1%
2021 -1.2% -3.1% 3.6% 4.0% 3.6%
2022 -4.9% 6.2% 5.8% 4.9%
2023 18.5% 11.6% 8.3%
2024 5.1% 3.6%
2025 2.1%
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
2011 - - - - - - - - - - - - - - -
2012 - - - - - - - - - - - - - -
2013 - - - - - - - - - - - - -
2014 - - - - - - - - - - - -
2015 - - - - - - - - - - -
2016 - - - - - - - - - -
2017 0.6% -2.6% -1.6% 47.9% 35.1% 25.4% 22.8% 21.2% 20.0%
2018 -5.8% -2.7% 68.2% 45.4% 31.0% 26.9% 24.5% 22.6%
2019 0.4% 124.7% 68.0% 42.3% 34.7% 30.4% 27.3%
2020 403.0% 117.4% 59.8% 44.9% 37.4% 32.5%
2021 -6.0% -9.9% -4.3% -0.7% 1.4%
2022 -13.6% -3.4% 1.1% 3.4%
2023 8.1% 9.4% 9.8%
2024 10.8% 10.7%
2025 10.5%

Distributions

Last updated: Jun 15, 2026

Profit Margin Distribution

< 0%
12%
1y 3y 1% 3%
0 - 5%
25%
1y 3y 0% 0%
5 - 10%
2%
1y 3y 0% 97%
10 - 15%
0%
1y 3y 99% 0%
15 - 20%
62%
1y 3y 0% 0%
20 - 30%
0%
1y 3y 0% 0%
30 - 40%
0%
1y 3y 0% 0%
> 40%
0%
1y 3y 0% 0%
< 0%
79%
1y 3y 73% 88%
0 - 5%
7%
1y 3y 0% 0%
5 - 10%
2%
1y 3y 0% 6%
10 - 15%
0%
1y 3y 7% 0%
15 - 20%
2%
1y 3y 0% 0%
20 - 30%
2%
1y 3y 0% 0%
30 - 40%
0%
1y 3y 0% 0%
> 40%
7%
1y 3y 20% 6%

P/E Ratio Distribution

< 0
11%
1y 3y 100% 20%
0 - 10
0%
1y 3y 0% 80%
10 - 15
0%
1y 3y 0% 0%
15 - 20
63%
1y 3y 0% 0%
20 - 25
0%
1y 3y 0% 0%
25 - 35
11%
1y 3y 0% 0%
35 - 50
13%
1y 3y 0% 0%
> 50
3%
1y 3y 0% 0%
< 0
88%
1y 3y 83% 7%
0 - 10
6%
1y 3y 8% 93%
10 - 15
0%
1y 3y 0% 0%
15 - 20
1%
1y 3y 0% 0%
20 - 25
0%
1y 3y 0% 0%
25 - 35
1%
1y 3y 0% 0%
35 - 50
1%
1y 3y 0% 0%
> 50
2%
1y 3y 8% 0%

Discounted Cash Flow

Weighted Average Undervaluation
N/A
Undervalued
> 60%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
15 - 30%
0%
1y 3y N/A N/A
Fair (&plusmn;15%)
0%
1y 3y N/A N/A
Overvalued
15 - 30%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
> 60%
0%
1y 3y N/A N/A
Equal Weight Average Undervaluation
N/A
Undervalued
> 60%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
15 - 30%
0%
1y 3y N/A N/A
Fair (&plusmn;15%)
0%
1y 3y N/A N/A
Overvalued
15 - 30%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
> 60%
0%
1y 3y N/A N/A

Portfolio Concentration

*by Market Cap Last updated: Jun 15, 2026
89.3% Top 5 Holdings
94.6% Top 10 Holdings
100.0% Top 50 Holdings
100.0% Top 100 Holdings
Top 5 Companies
BSX-PA Boston Scientific Corporation
56.9%
SDZNY Sandoz Group AG
11.8%
MDLN Medline Inc.
10.0%
UXI BioAge Labs, Inc.
9.0%
BLLN BillionToOne, Inc.
1.5%

Market Cap Size Distribution

Micro Cap
0.8%
1y 3y 0.4% 2.4%
Small Cap
4.6%
1y 3y 1.0% 3.2%
Mid Cap
6.8%
1y 3y 0.0% 0.0%
Large Cap
87.8%
1y 3y 98.6% 94.5%
Mega Cap
0.0%
1y 3y 0.0% 0.0%
Micro: < $300M Small: $300M–$2B Mid: $2B–$10B Large: $10B–$200B Mega: > $200B
Micro Cap
68.6%
1y 3y 84.0% 77.8%
Small Cap
19.8%
1y 3y 12.0% 18.5%
Mid Cap
7.0%
1y 3y 0.0% 0.0%
Large Cap
4.7%
1y 3y 4.0% 3.7%
Mega Cap
0.0%
1y 3y 0.0% 0.0%
Micro: < $300M Small: $300M–$2B Mid: $2B–$10B Large: $10B–$200B Mega: > $200B

Average metrics of all companies in sector Last updated: Jun 21, 2026

Compare to
Market
Market Cap The average market value of companies in this sector. $18.9B
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 0.2 %
Beta Indicates the relationship between the price performance of a share and the market. 0.78
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 27.22
Negative P/E Ratio A negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything. -36.06
Profitable Companies 92%
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 3.76
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 7.5
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company. 6.17
Compare to
Market
Enterprise Value to EBIT Enterprise Value divided by EBIT. 40.2
Enterprise Value to Revenue Enterprise value divided by revenue. 7.28
Total Debt to Enterprise Value Total debt divided by enterprise value. 0.09
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 0.46
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. 12.02%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. +10.3%
Return on Equity Equity divided by market cap. 6.04%
Return on Assets Indicates a company's profitability in relation to its total assets. 1.90%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 3.63%

Stock Screener

Select filters to narrow down the 278 companies below

278 companies
$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%
Market Cap $175.45B
Dividends 0.0%
P/E Ratio 18.9
Revenue $5.2B +11.6%
Net Income $1.34B +98.4%
Profit Margin +25.7%
Employees 45K
View Stock
Market Cap $175.45B
Dividends 0.0%
P/E Ratio 18.9
Revenue $5.2B +11.6%
Net Income $1.34B +98.4%
Profit Margin +25.7%
Employees 45K
View Stock
Market Cap $36.48B
Dividends 1.2%
P/E Ratio 39.5
Revenue $4.64B -4.0%
Net Income $425M -412.5%
Profit Margin +9.2%
Employees 22.05K
View Stock
Market Cap $30.39B
Dividends 0.0%
P/E Ratio 30.5
Revenue $7.35B
Net Income $129M
Profit Margin +1.8%
Employees 43K
View Stock
Market Cap $29.76B
Dividends 5.7%
P/E Ratio -37.1
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $29.76B
Dividends 4.5%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $29.76B
Dividends 12.6%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $29.76B
Dividends 4.7%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $29.76B
Dividends 3.7%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $29.76B
Dividends 3.5%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $29.76B
Dividends 4.2%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $29.76B
Dividends 7.9%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $29.76B
Dividends 6.8%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $29.76B
Dividends
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $29.76B
Dividends 1.7%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $29.76B
Dividends 1.4%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $29.76B
Dividends 2.2%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $29.76B
Dividends 5.2%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $29.76B
Dividends 2.8%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $29.76B
Dividends 5.8%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock